ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 57 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $612,265 | +18.6% | 53,473 | +6.5% | 0.00% | – |
Q2 2023 | $516,097 | +139.5% | 50,204 | +79.9% | 0.00% | – |
Q1 2023 | $215,496 | +67.0% | 27,914 | +59.0% | 0.00% | – |
Q4 2022 | $129,073 | +53.7% | 17,561 | +51.9% | 0.00% | – |
Q3 2022 | $84,000 | -25.0% | 11,562 | -12.4% | 0.00% | – |
Q2 2022 | $112,000 | +34.9% | 13,199 | +42.3% | 0.00% | – |
Q1 2022 | $83,000 | -34.6% | 9,277 | +1.4% | 0.00% | – |
Q4 2021 | $127,000 | +353.6% | 9,145 | +234.5% | 0.00% | – |
Q3 2021 | $28,000 | -6.7% | 2,734 | -17.8% | 0.00% | – |
Q2 2021 | $30,000 | -47.4% | 3,326 | -37.8% | 0.00% | – |
Q1 2021 | $57,000 | -98.8% | 5,350 | -98.6% | 0.00% | -100.0% |
Q4 2020 | $4,759,000 | +22561.9% | 377,723 | +15527.8% | 0.00% | – |
Q3 2020 | $21,000 | -47.5% | 2,417 | -40.7% | 0.00% | – |
Q2 2020 | $40,000 | – | 4,075 | +58114.3% | 0.00% | – |
Q1 2020 | $0 | – | 7 | -66.7% | 0.00% | – |
Q4 2019 | $0 | – | 21 | -16.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 25 | -99.6% | 0.00% | – |
Q2 2019 | $29,000 | -35.6% | 6,879 | +5.2% | 0.00% | – |
Q1 2019 | $45,000 | +55.2% | 6,538 | -14.9% | 0.00% | – |
Q4 2018 | $29,000 | +314.3% | 7,684 | +641.0% | 0.00% | – |
Q3 2018 | $7,000 | -12.5% | 1,037 | 0.0% | 0.00% | – |
Q2 2018 | $8,000 | -27.3% | 1,037 | -28.1% | 0.00% | – |
Q1 2018 | $11,000 | -8.3% | 1,443 | +39.2% | 0.00% | – |
Q4 2017 | $12,000 | -58.6% | 1,037 | -59.1% | 0.00% | – |
Q3 2017 | $29,000 | – | 2,537 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,571,450 | $23,143,000 | 2.13% |
Omega Fund Management, LLC | 1,284,900 | $11,564,000 | 1.31% |
Avidity Partners Management LP | 1,495,000 | $13,455,000 | 0.36% |
Samsara BioCapital, LLC | 275,169 | $2,477,000 | 0.31% |
Orbimed Advisors | 3,070,955 | $27,639,000 | 0.28% |
Ikarian Capital, LLC | 300,454 | $2,704,000 | 0.22% |
TIGER MANAGEMENT L.L.C. | 137,728 | $1,240,000 | 0.22% |
DAFNA Capital Management LLC | 113,302 | $1,020,000 | 0.21% |
EcoR1 Capital, LLC | 522,635 | $4,704,000 | 0.18% |
Artal Group S.A. | 593,030 | $5,337,000 | 0.11% |